Skip to main content
Fig. 8 | Journal of Translational Medicine

Fig. 8

From: A novel stemness-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity of clear cell renal cell carcinoma

Fig. 8

Potential therapeutic drugs for ccRCC based on SRlncRNA signature. A Different drug sensitivities of samples in low- and high-risk groups. The lower the IC50 value, the higher the sensitivity of the drug. B Intersection of the candidate drugs in L1000FWD, CMap and DGIdb database. C Structures of the candidate drugs in the intersection

Back to article page